Lupeol CAS 545-47-1

130610

Synonyms: Monogynol B, (+)-Lupeol, Clerodol, Fagarasterol, Lupenol, β-Viscol

 

50 mg € 130
100 mg € 180
250 mg € 340
500 mg € 610
For bulk quantities contact us at [email protected]
Cat. No. NST-10-174
CAS 545-47-1
Purity 98% (HPLC)
Plant Birch bark
Appearance White powder
Molecular formula C30H50O
Molecular weight 426,73
Storage +2 … +8 °C

Certificate of analysis available by request to [email protected]

SKU: N/A Categories: ,
Description

Lupeol: Unveiling the Potential of a Versatile Triterpene

1. Molecular Identity

  • Chemical Name: (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol
  • CAS Number: 545-47-1
  • Source: Widely distributed in various plant species, including fruits, vegetables, and medicinal plants

2. Biochemical Significance

Lupeol is a pentacyclic triterpene with a diverse range of biological activities. Its unique molecular structure allows it to interact with multiple cellular targets, making it a compound of significant interest in natural product research and potential therapeutic applications.

3. Key Therapeutic Properties

  • Anti-inflammatory: Demonstrates potent anti-inflammatory effects
  • Anticancer: Shows promise in inhibiting various cancer cell lines
  • Antioxidant: Exhibits free radical scavenging activity
  • Cardioprotective: Displays potential in supporting cardiovascular health

4. Potential Applications

  • Cancer research and chemoprevention studies
  • Inflammatory disorder investigations
  • Cardiovascular disease research
  • Skin health and cosmeceutical development

5. Current Research Focus

Ongoing studies are investigating Lupeol’s effects on:

  • Various cancer types and mechanisms of action
  • Inflammatory signaling pathways
  • Cardiovascular disease models
  • Skin aging and photoprotection

6. Formulation Challenges and Innovations

Researchers are actively working on:

  • Enhancing bioavailability through novel delivery systems
  • Developing topical formulations for dermatological applications
  • Creating stable preparations for various research and therapeutic uses

7. Regulatory Considerations

As a naturally occurring compound found in many edible plants, Lupeol (CAS 545-47-1) has a generally favorable safety profile. However, its use as a therapeutic agent would require thorough safety and efficacy evaluations to meet regulatory standards.

8. Future Directions

The scientific community anticipates:

  • Advanced clinical trials for specific indications, particularly in cancer and inflammation
  • Exploration of synergistic effects with other natural compounds
  • Development of semi-synthetic derivatives with enhanced properties

9. Collaborative Opportunities

We invite researchers, pharmaceutical companies, and academic institutions to explore the research potential of Lupeol. For inquiries, collaborations, or to discuss how Lupeol can benefit your research projects, please contact us at [email protected].

Join us in unlocking the potential of Lupeol – a versatile triterpene at the forefront of natural product research and innovative therapeutic strategies.